ANTONAZZO IPPAZIO COSIMO

Antonazzo, I., Rozza, D., Cortesi, P., Fornari, C., Zanzottera Ferrari, E., Paris, C., et al. (2025). Generalizability and treatment with sodium-glucose co-trasporter-2 inhibitors (SGLT2i) among patients with type 2 diabetes: an assessment using an Italian primary care database. ACTA DIABETOLOGICA, 62(3), 343-351 [10.1007/s00592-024-02359-1]. Detail

Ferrara, P., Monti, C., Rozza, D., Fornari, C., Antonazzo, I., Ferrara, M., et al. (2025). Incidence and risk factors for falls among nursing home residents in Italy: a retrospective cohort study. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 37(1) [10.1007/s40520-025-03111-7]. Detail

Losa, L., Antonazzo, I., Di Martino, G., Mazzaglia, G., Tafuri, S., Mantovani, L., et al. (2024). Immunogenicity of Recombinant Zoster Vaccine: A Systematic Review, Meta-Analysis, and Meta-Regression. VACCINES, 12(5) [10.3390/vaccines12050527]. Detail

Ponticelli, D., Losa, L., Antonazzo, I., Zampella, A., Di Marino, F., Mottola, G., et al. (2024). Respiratory Syncytial Virus (RSV) and Intention to Recommend RSV Vaccination: A Cross-Sectional Survey of Cardiologists and Cardiac Nurses in Southern Italy. INFECTIOUS DISEASE REPORTS, 16(1), 128-141 [10.3390/idr16010010]. Detail

Mazzaglia, G., Antonazzo, I., Mol, P. (2024). Risk management and drug utilization research. In Drug Utilization Research: Methods and Applications (pp. 428-436). wiley [10.1002/9781119911685.ch42]. Detail